A Shanghai leather factory owned by Mainzeal's parent company Richina was previously sanctioned for violating Shanghai's air pollution rules.
Richina was founded in 1995 by Richard Yan, the sole director of Mainzeal, which put itself into receivership this week.
Richina bought Mainzeal in 1995, along with a New Zealand leather company Mair Astley, later adding a Chinese leather company to its assets.
That plant in Shanghai – the Richina Leather factory – has been the source of considerable pollution issues for locals in the Jufengyuan neighbourhood in the city's north-east, about 2km from the factory.
According to a report by China Dialogue in 2010, Richina was sanctioned annually from 2004-08 for air pollution breaches.
In 2008 alone, it was prosecuted for turning off air-treatment equipment and fined about $US15,000 for violating standards on the release of atmospheric pollutants.
Locals complained about the putrid odours being emitted from the plant, which supplies tanned leather to some of the world's largest shoe, clothing, furnishing and car brands such as Toyota and Nike.
Richina ceo Bob Moore claimed to know nothing about the odour, saying it was coming from other chemical plants.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Marlborough-based wine company lists on the NXT despite OIO hiccup
- Land banking in Auckland is causing the housing crisis: LGNZ
- Z Energy savings from Caltex acquisiton on track
- New lawyers not doing 'much better' than job at McDonald's – report surprises
- Editor's Insight: Med-tech sees future in transforming healthcare
Most listened to
- Marlborough Wine Estates CEO Catherine Ma explains why the Chinese-owned company listed on the NXT
- National list MP Chris Bishop says Phil Twyford's accusation the government has made housing a 'race issue' is hypocritical
- Bond prices have fallen while oil prices have risen - Jason Walls explains why on Walls' Street
- NBR technology editor Chris Keall on hitting 4000 member subscribers
- In his Editor's Insight Nevil Gibson on the future of health information technology and medical devices industry